Healthcare leads the charge with multiple large-cap stocks (CI, CVS, HCA) recently rated strong buy on Monday. Technology also sees significant analyst conviction with upgrades to PANW and BIDU over the past few days. Average target price upside across these names suggests continued momentum. However, a notable downgrade of CRM to Hold signals caution in the software sector.
Disclaimer: This article is for informational purposes only and does not constitute financial advice. We are not financial professionals. The authors and/or site operators may hold positions in the companies or assets mentioned. Always do your own research before making financial decisions.
Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications.